Bortezomib

MAPK activated protein kinase 2 ; Homo sapiens







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31440466 Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma. 2019 1
2 15480425 p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells. 2004 Nov 18 1